Related Experiment Video
Updated: Jun 3, 2026
09:15
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Rosuvastatin: efficacy, safety and clinical effectiveness
Handrean Soran1, Paul Durrington
1Central Manchester and Manchester Children University Hospital, Department of Endocrinology, Oxford Road, Manchester M13 9WL, UK.
Expert Opinion on Pharmacotherapy
|August 2, 2008
Summary
Rosuvastatin effectively lowers low-density lipoprotein cholesterol (LDL-C) and may offer benefits for other lipids. While promising, more cardiovascular outcome data are needed to confirm its superiority over other statins.
Area of Science:
- Pharmacology
- Cardiovascular Medicine
Background:
- Rosuvastatin is a synthetic statin medication.
- It functions as a competitive inhibitor of 3-hydroxy-3-methyl-glutaryl-CoA reductase.
Purpose of the Study:
- To review the efficacy, characteristics, safety, and clinical effectiveness of rosuvastatin.
- Assess rosuvastatin's impact on lipid profiles and potential cardiovascular benefits.
Main Methods:
- Comprehensive literature search of Pubmed and Medline databases (January 2000 - March 2008).
- Inclusion of English-language publications on rosuvastatin.
- Supplemented with references from personal collections and textbooks.
Main Results:
- Rosuvastatin demonstrates potent low-density lipoprotein cholesterol (LDL-C) reduction.
- Potential favorable effects on high-density lipoprotein (HDL), non-HDL-C, and triglycerides observed.
- Vascular imaging studies show encouraging results, but definitive cardiovascular outcome data are pending.
Conclusions:
- Rosuvastatin exhibits significant LDL-C lowering capabilities and may improve other lipid parameters.
- While theoretically promising for cardiovascular outcomes, robust trial data are still limited.
- Early results from one outcome trial suggest clear benefits compared to placebo, leading to its early termination.
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:18Cardiovascular Drugs: Classification based on Therapeutic Indications
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However, frequent irregular...
01:29Cholesterol: Significance and Regulation
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
01:27Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...